Summary
- Current Price
- As of today, AMLX price is $38.66, down -2.52% on
- Current Price All-Time High
- AMLX price is currently -7.80% below its historical high of $41.93 set on
- Market Cap
- AMLX current market cap is $4B, up +473.13% over the past 365 days
- Revenue
- AMLX current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for AMLX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Amylyx Pharmaceuticals, Inc. |
| Ticker | NASDAQ: AMLX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | amylyx.com |
| Employees | 123 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $38.66 | |
| Price, 1D Change | -2.52% | |
| $4B | ||
| - | ||
| - | ||
| 0.84 | ||
| $0.00 | ||
| Revenue, 1Y Change | -100.00% | |
| -$1.53 | ||
| EPS, 1Y Change | +65.44% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.53 | ||
| EPS Estimate | -$1.47 | N/A |
| EPS Est. Change | +3.87% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $38.66 | |
| Price Target | $27.00 | - |
| Price Tgt. Change | -30.16% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.30 | -$4.43 | -3.10% | |
| -$1.52 | -$1.53 | -0.96% | |
| -$1.47 | N/A | +3.87% | |
| -$1.38 | N/A | +10.08% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $88.03M | $87.37M | -0.75% | |
| - | $0.00 | - | |
| - | N/A | - | |
| $29.64M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $38.66 | |
| $15.74 | ||
| $20.27 | ||
| $16.21 | ||
| $21.85 | ||
| $4.61 | ||
| 0.84 | ||
| $2.42 | ||
| 82.13 | ||
| 325.12% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.53 | ||
| -$525.00K | ||
| - | ||
| -$153.29M | ||
| - | ||
| -$144.74M | ||
| - | ||
| -$152.77M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 14.27 | ||
| 14.27 | ||
| - | ||
| - | ||
| 86.11 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 18.01 | ||
| -25.12 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $305.26M | ||
| $316.98M | ||
| $334.07M | ||
| $323.67M | ||
| $28.82M | ||
| $22.69M | ||
| $5.96M | ||
| $1.26M | ||
| $3.52M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $144.74M | ||
| $152.77M | ||
| $525.00K | ||
| $0.00 | ||
| $525.00K | ||
| $0.00 | ||
| $46.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$123.34M | ||
| $14.04M | ||
| $257.03M | ||
| $138.00K | ||
| -$123.48M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Citigroup | → | |
| Mizuho | → | |
| Guggenheim | → | |
| Mizuho | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| Stifel | ||
| B of A Securities | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with AMLX
FAQ
- What is the ticker symbol for Amylyx Pharmaceuticals, Inc.?
- The ticker symbol for Amylyx Pharmaceuticals, Inc. is NASDAQ:AMLX
- Does Amylyx Pharmaceuticals, Inc. pay dividends?
- No, Amylyx Pharmaceuticals, Inc. does not pay dividends
- What sector is Amylyx Pharmaceuticals, Inc. in?
- Amylyx Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Amylyx Pharmaceuticals, Inc. in?
- Amylyx Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Amylyx Pharmaceuticals, Inc. based in?
- Amylyx Pharmaceuticals, Inc. is headquartered in United States
- When did Amylyx Pharmaceuticals, Inc. go public?
- Amylyx Pharmaceuticals, Inc. initial public offering (IPO) was on January 7, 2022
- Is Amylyx Pharmaceuticals, Inc. in the S&P 500?
- No, Amylyx Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Amylyx Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Amylyx Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Amylyx Pharmaceuticals, Inc. in the Dow Jones?
- No, Amylyx Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Amylyx Pharmaceuticals, Inc. last earnings report?
- Amylyx Pharmaceuticals, Inc.'s most recent earnings report was on August 6, 2026
- When does Amylyx Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Amylyx Pharmaceuticals, Inc. is November 5, 2026
Data Sources & References
- AMLX Official Website amylyx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1658551/000119312526086645/0001193125-26-086645-index.htm
- AMLX Profile on Yahoo Finance finance.yahoo.com/quote/AMLX
- AMLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amlx